SBIR/STTR Research Award
MINIATURE BLOOD CELL COUNTER FOR NEUROLOGICAL DISORDERS
Award amount
$991,066Program and phase
SBIR · Phase IIAward year
2002Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- LEHDAR SYSTEMS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION: (Applicant's abstract) Many clinical/medical conditions, i.e,
neurological emergencies and disorders, require rapid intervention. Stroke is
one example. In this context, availability of medical devices can enhance
medical care to the patient.
Blood cell counters, which are used to count blood components such as red and
white blood cells, are ubiquitous in medicine as a diagnostic aid for disease
identification or as a general tool for many medical therapies. The pre-eminent
device in use today is the Coulter counter, which is expensive, large, and
generally not portable, requiring at least a desktop, household current supply
and a small support laboratory. The goal of this research and development
project is to design a prototype miniature blood cell counter for home-care, or
point-of-care analysis in doctors' offices, clinics, and hospitals.
The novel blood counter we propose to develop is based on new, emerging
micromachine technologies, and would be approximately the size of a small
cell-phone, requiring very low electrical power. Similar to an inkjet print
head, which is also a product of micromachined fluidics technology, the core
analytical components of the miniature blood counter would be inexpensively
mass-produced. The cost per unit would be low enough that the analytical
portion could here placed after each use.
PROPOSED COMMERCIAL APPLICATION:
The proposed device has several likely economic advantages. Firstly, it will reduce the
need for and cost of transport of blood samples to centralized laboratory. Secondly,
expedient diagnosis will mean fewer clinical complications fewer office visits, shorter
hospital stays and possible a reduced need to transport patients. It could result in an
overall savings of several million dollars annually.
Technology keywords
Not reported